Background: Colorectal cancer (CRC) is a common malignant tumor. N-Methyladenosine (mA) modification plays an important role in the regulation of glycolysis in tumor cells and may be a potential target for tumor therapy.
Methods: The role of METTL14, an mA writer, in CRC was investigated through functional assays including cell viability, colony formation, and glycolysis-related measurements (glucose uptake, lactate production, extracellular acidification rate (ECAR) and oxygen consumption rate (OCR)). The target gene regulated by METTL14 in an mA-dependent manner was identified using molecular biology techniques. In addition, CRC cells overexpressing METTL14 were subcutaneously injected into mice to verify the regulatory effect of METTL14 on tumor growth in vivo.
Results: Our data suggested that METTL14 was up-regulated in CRC cell lines, and over-expression of METTL14 suppressed cell proliferation and glycolysis. Meanwhile, ATF2 mA level was significantly up-regulated by over-expression of METTL14, and the binding relationship between ATF2 and METTL14 was further verified. METTL14-mA regulated ATF2 in CRC cells participates in the regulation of glycolysis. METTL14 also suppressed tumorigenesis of nude mice.
Conclusion: Intervention with METTL14 mediated mA modifications or its associated protein ATF2 may provide new strategies for CRC therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11844156 | PMC |
| http://dx.doi.org/10.1186/s12885-025-13532-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Specific sDMA modifications on the RGG/RG motif of METTL14 regulate its function in AML.
Cell Commun Signal
March 2025
School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.
Background: Protein arginine methylations are crucial post-translational modifications (PTMs) in eukaryotes, playing a significant regulatory role in diverse biological processes. Here, we present our investigation into the detailed arginine methylation pattern of the C-terminal RG-rich region of METTL14, a key component of the m6A RNA methylation machinery, and its functional implications in biology and disease.
Methods: Using ETD-based mass spectrometry and in vitro enzyme reactions, we uncover a specific arginine methylation pattern on METTL14.
The Erk1/2-EGR1 signaling pathway is involved in lipopolysaccharide-induced transforming growth factor-beta 1 expression in mouse macrophages.
Microb Pathog
March 2025
Jiangsu Province Engineering Research Center of Precision Animal Breeding, Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, China; College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China. Electronic address:
Numerous studies have demonstrated that lipopolysaccharide (LPS) stimulates TGF-β1 expression. Although studies have implicated the NF-κB/METTL3/METTL14 transactivation/m6A-dependent and AMPK-dependent signaling pathways are engaged in this process in a variety of cell types, the underlying regulatory mechanism in murine macrophages is still not fully understood. To address this issue, in vitro studies were performed using the murine macrophage cell line, RAW264.
View Article and Find Full Text PDFExon junction complexes regulate osteoclast-induced bone resorption by influencing the NFATc1 m6A distribution through the "shield effect".
Clin Transl Med
March 2025
Department of General Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai, China.
Background: The distribution of the m6A methylation modification on the transcriptome is highly regionally selective and is mainly concentrated in abnormally long exons and stop codons. However, in-depth research on the selective mechanism of m6A methylation is still lacking.
Methods: In this research, meRIP sequencing, mRNA sequencing, meRIP, luciferase reporter assays and CRISPR/Cas9 conditional knockout mice were used to elucidate the distribution characteristics of NFATc1 m6A.
JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis.
J Transl Med
February 2025
Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Background: The Jumonji domain-containing protein 6 (JMJD6), a histone arginine demethylase, is known to have a multifaceted and significant role on cancer progression. However, the specific function and mechanism of JMJD6 in non-small cell lung cancer (NSCLC) have yet to be fully elucidated.
Methods: The elevated expression of JMJD6 in lung cancer tissues was confirmed through a combination of bioinformatics and immunohistochemical analysis.
Mechanism of lncRNA ZFAS1 mediating nucleus pulposus cell pyroptosis in intervertebral disc degeneration.
J Orthop Surg Res
February 2025
Department of Minimally Invasive Spine Surgery, Bengbu First People's Hospital, Bengbu, 233000, China.
Article Synopsis
- The study explores how lncRNA ZFAS1 contributes to a type of cell death called pyroptosis in intervertebral disc degeneration caused by TNF-α.
- Silencing ZFAS1 reduces pyroptosis in these nucleus pulposus cells (NPCs) by altering the interaction between miR-155-3p and METTL14, which are key players in this process.
- The findings suggest that targeting the ZFAS1/miR-155-3p/METTL14 pathway could have potential therapeutic implications for treating intervertebral disc degeneration.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!